These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 15089977)

  • 1. Homo- and hetero-dimeric complex formations of the human oxytocin receptor.
    Devost D; Zingg HH
    J Neuroendocrinol; 2004 Apr; 16(4):372-7. PubMed ID: 15089977
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Homo- and hetero-oligomeric interactions between G-protein-coupled receptors in living cells monitored by two variants of bioluminescence resonance energy transfer (BRET): hetero-oligomers between receptor subtypes form more efficiently than between less closely related sequences.
    Ramsay D; Kellett E; McVey M; Rees S; Milligan G
    Biochem J; 2002 Jul; 365(Pt 2):429-40. PubMed ID: 11971762
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Constitutive formation of oligomeric complexes between family B G protein-coupled vasoactive intestinal polypeptide and secretin receptors.
    Harikumar KG; Morfis MM; Lisenbee CS; Sexton PM; Miller LJ
    Mol Pharmacol; 2006 Jan; 69(1):363-73. PubMed ID: 16244179
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oxytocin and vasopressin V1a and V2 receptors form constitutive homo- and heterodimers during biosynthesis.
    Terrillon S; Durroux T; Mouillac B; Breit A; Ayoub MA; Taulan M; Jockers R; Barberis C; Bouvier M
    Mol Endocrinol; 2003 Apr; 17(4):677-91. PubMed ID: 12554793
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of dimeric and oligomeric complexes of the human oxytocin receptor by co-immunoprecipitation and bioluminescence resonance energy transfer.
    Devost D; Zingg HH
    J Mol Endocrinol; 2003 Dec; 31(3):461-71. PubMed ID: 14664707
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Past, present and future of vasopressin and oxytocin receptor oligomers, prototypical GPCR models to study dimerization processes.
    Cottet M; Albizu L; Perkovska S; Jean-Alphonse F; Rahmeh R; Orcel H; Méjean C; Granier S; Mendre C; Mouillac B; Durroux T
    Curr Opin Pharmacol; 2010 Feb; 10(1):59-66. PubMed ID: 19896898
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Melanocortin receptors form constitutive homo- and heterodimers.
    Mandrika I; Petrovska R; Wikberg J
    Biochem Biophys Res Commun; 2005 Jan; 326(2):349-54. PubMed ID: 15582585
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oxytocin receptors: ligand binding, signalling and cholesterol dependence.
    Gimpl G; Reitz J; Brauer S; Trossen C
    Prog Brain Res; 2008; 170():193-204. PubMed ID: 18655883
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Binding domains of the oxytocin receptor for the selective oxytocin receptor antagonist barusiban in comparison to the agonists oxytocin and carbetocin.
    Gimpl G; Postina R; Fahrenholz F; Reinheimer T
    Eur J Pharmacol; 2005 Mar; 510(1-2):9-16. PubMed ID: 15740719
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hetero-oligomerization between adenosine A₁ and thromboxane A₂ receptors and cellular signal transduction on stimulation with high and low concentrations of agonists for both receptors.
    Mizuno N; Suzuki T; Hirasawa N; Nakahata N
    Eur J Pharmacol; 2012 Feb; 677(1-3):5-14. PubMed ID: 22200626
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assembly and signaling of CRLR and RAMP1 complexes assessed by BRET.
    Héroux M; Breton B; Hogue M; Bouvier M
    Biochemistry; 2007 Jun; 46(23):7022-33. PubMed ID: 17503773
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oligomerization of the alpha and beta isoforms of the thromboxane A2 receptor: relevance to receptor signaling and endocytosis.
    Laroche G; Lépine MC; Thériault C; Giguère P; Giguère V; Gallant MA; de Brum-Fernandes A; Parent JL
    Cell Signal; 2005 Nov; 17(11):1373-83. PubMed ID: 15893915
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cholesterol as modulator of receptor function.
    Gimpl G; Burger K; Fahrenholz F
    Biochemistry; 1997 Sep; 36(36):10959-74. PubMed ID: 9283088
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Investigation of mechanism of desmopressin binding in vasopressin V2 receptor versus vasopressin V1a and oxytocin receptors: molecular dynamics simulation of the agonist-bound state in the membrane-aqueous system.
    Slusarz MJ; Slusarz R; Ciarkowski J
    Biopolymers; 2006 Apr; 81(5):321-38. PubMed ID: 16333859
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Constitutive homo- and hetero-oligomerization of TbetaRII-B, an alternatively spliced variant of the mouse TGF-beta type II receptor.
    Krishnaveni MS; Hansen JL; Seeger W; Morty RE; Sheikh SP; Eickelberg O
    Biochem Biophys Res Commun; 2006 Dec; 351(3):651-7. PubMed ID: 17078931
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of extracellular cysteine residues in dimerization/oligomerization of the human prostacyclin receptor.
    Giguère V; Gallant MA; de Brum-Fernandes AJ; Parent JL
    Eur J Pharmacol; 2004 Jun; 494(1):11-22. PubMed ID: 15194446
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of interactions responsible for vasopressin binding to human neurohypophyseal hormone receptors-molecular dynamics study of the activated receptor-vasopressin-G(alpha) systems.
    Slusarz MJ; Giełdoń A; Slusarz R; Ciarkowski J
    J Pept Sci; 2006 Mar; 12(3):180-9. PubMed ID: 16114100
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Formation of oligomers by G protein-coupled receptors.
    Gazi L; López-Giménez JF; Strange PG
    Curr Opin Drug Discov Devel; 2002 Sep; 5(5):756-63. PubMed ID: 12630296
    [TBL] [Abstract][Full Text] [Related]  

  • 19. B1 bradykinin receptor homo-oligomers in receptor cell surface expression and signaling: effects of receptor fragments.
    Kang DS; Gustafsson C; Mörgelin M; Leeb-Lundberg LM
    Mol Pharmacol; 2005 Jan; 67(1):309-18. PubMed ID: 15492119
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hetero-oligomerization and specificity changes of G protein-coupled purinergic receptors: novel insight into diversification of signal transduction.
    Suzuki T; Namba K; Mizuno N; Nakata H
    Methods Enzymol; 2013; 521():239-57. PubMed ID: 23351743
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.